COMPANY
more from company profile
HomeMarket Info Company Profile Financial Ratios

Financial Ratios

ASTRAZENECA PHARMA INDIA LTD.

NSE : ASTRAZENBSE : 506820ISIN CODE : INE203A01020Industry : Pharmaceuticals & DrugsHouse : Astrazeneca Pharma India - MNC
BSE5415.40115.4 (+2.18 %)
PREV CLOSE ( ) 5300.00
OPEN PRICE ( ) 5381.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1499
TODAY'S LOW / HIGH ( )5349.25 5514.70
52 WK LOW / HIGH ( )3128.5 7208
NSE5425.8093.55 (+1.75 %)
PREV CLOSE( ) 5332.25
OPEN PRICE ( ) 5377.00
BID PRICE (QTY) 5425.80 (55)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 11479
TODAY'S LOW / HIGH( ) 5335.35 5520.00
52 WK LOW / HIGH ( )3125 7220.95
Select year
Particulars
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
Operational & Financial Ratios
 
 
 
 
 
   Earnings Per Share (Rs)
39.72  
24.64  
37.32  
28.88  
21.78  
   CEPS(Rs)
46.22  
31.42  
45.37  
36.32  
27.75  
   DPS(Rs)
16.00  
10.00  
2.00  
1.00  
0.00  
   Book NAV/Share(Rs)
234.45  
203.78  
181.83  
145.14  
119.48  
   Tax Rate(%)
25.96  
25.82  
26.59  
36.64  
25.07  
Margin Ratios
 
 
 
 
 
   Core EBITDA Margin(%)
16.39  
10.65  
16.58  
14.45  
9.74  
   EBIT Margin(%)
13.37  
10.38  
15.69  
13.78  
9.93  
   Pre Tax Margin(%)
13.31  
10.26  
15.56  
13.64  
9.93  
   PAT Margin (%)
9.85  
7.61  
11.42  
8.65  
7.44  
   Cash Profit Margin (%)
11.47  
9.70  
13.88  
10.87  
9.48  
Performance Ratios
 
 
 
 
 
   ROA(%)
9.37  
6.65  
11.31  
10.57  
9.34  
   ROE(%)
18.13  
12.78  
22.83  
21.83  
20.03  
   ROCE(%)
24.49  
17.36  
31.24  
34.61  
26.53  
   Asset Turnover(x)
0.95  
0.87  
0.99  
1.22  
1.25  
   Sales/Fixed Asset(x)
5.79  
4.93  
5.58  
6.61  
6.48  
   Working Capital/Sales(x)
2.23  
2.17  
2.59  
3.88  
5.02  
Efficiency Ratios
 
 
 
 
 
   Fixed Capital/Sales(x)
0.17  
0.20  
0.18  
0.15  
0.15  
   Receivable days
35.03  
38.57  
37.62  
35.61  
33.52  
   Inventory Days
59.85  
67.64  
72.59  
61.89  
57.68  
   Payable days
214.92  
220.48  
246.52  
229.92  
237.77  
Valuation Parameters
 
 
 
 
 
   PER(x)
81.76  
103.71  
80.66  
82.80  
91.75  
   PCE(x)
70.26  
81.33  
66.34  
65.85  
72.02  
   Price/Book(x)
13.85  
12.54  
16.55  
16.48  
16.72  
   Yield(%)
0.49  
0.39  
0.07  
0.04  
0.00  
   EV/Net Sales(x)
7.60  
7.37  
8.82  
6.88  
6.62  
   EV/Core EBITDA(x)
39.84  
58.85  
48.37  
42.83  
55.06  
   EV/EBIT(x)
56.54  
70.72  
55.96  
49.75  
66.36  
   EV/CE(x)
6.67  
6.08  
8.21  
7.38  
8.16  
   M Cap / Sales
8.09  
7.93  
9.25  
7.19  
6.86  
Growth Ratio
 
 
 
 
 
   Net Sales Growth(%)
24.50  
-0.98  
-2.19  
14.21  
27.55  
   Core EBITDA Growth(%)
89.44  
-31.94  
10.94  
52.63  
49.62  
   EBIT Growth(%)
60.41  
-34.47  
11.35  
58.40  
65.91  
   PAT Growth(%)
61.19  
-33.98  
29.21  
32.62  
110.15  
   EPS Growth(%)
61.19  
-33.98  
29.21  
32.62  
110.15  
Financial Stability Ratios
 
 
 
 
 
   Total Debt/Equity(x)
0.00  
0.00  
0.00  
0.00  
0.00  
   Current Ratio(x)
1.93  
1.95  
1.84  
1.59  
1.54  
   Quick Ratio(x)
1.54  
1.59  
1.42  
1.14  
1.10  
   Interest Cover(x)
213.86  
88.41  
117.60  
100.97  
NA  
   Total Debt/Mcap(x)
0.00  
0.00  
0.00  
0.00  
0.00  

© 2019. MSE Financial Services Ltd. All Rights Reserved

Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.